← Back to Search

Unknown

EDP-323 SAD Cohorts for Respiratory Syncytial Virus

Phase 1
Waitlist Available
Research Sponsored by Enanta Pharmaceuticals, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 14 days in mad cohorts
Awards & highlights

Study Summary

This trial tests the safety of a new drug in healthy adults. It will measure how the body processes the drug and how it is tolerated.

Eligible Conditions
  • Respiratory Syncytial Virus (RSV)

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 14 days in mad cohorts
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 14 days in mad cohorts for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Safety measured by adverse events
Secondary outcome measures
AUC of EDP-323
Cmax of EDP-323

Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: EDP-323 SAD CohortsExperimental Treatment1 Intervention
EDP-323 Dose 1, Dose 2, Dose 3, Dose 4, Dose 5 and Dose 6, orally, once daily in one single administration
Group II: EDP-323 MAD CohortsExperimental Treatment1 Intervention
EDP-323 Dose 1, Dose 2, Dose 3 and Dose 4 orally, once daily for 7 days
Group III: EDP-323 SAD Placebo CohortsPlacebo Group1 Intervention
Matching placebo, orally, once daily in one single administration
Group IV: EDP-323 MAD Placebo CohortsPlacebo Group1 Intervention
Matching placebo, orally, once daily for 7 days
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EDP-323
2022
Completed Phase 1
~90

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Enanta Pharmaceuticals, IncLead Sponsor
39 Previous Clinical Trials
2,902 Total Patients Enrolled
~31 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top